Physical symptoms distress index: A sensitive tool to evaluate the impact of pharmacological agents on quality of life

Archives of Internal Medicine

Volumn 159, Issue 7, 1999, Pages 693-700

  Anderson, Richard B ^a   Hollenberg, Norman K ^b   Williams, Gordon H ^b  

^a Commensa Inc ^*  (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE; VERAPAMIL;

ABDOMINAL CRAMP; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EDEMA; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE CRAMP; PATIENT COMPLIANCE; POLYURIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; STRESS; SUSTAINED RELEASE PREPARATION;

NON-PROGRAMMATIC;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CONSTIPATION; DOUBLE-BLIND METHOD; EDEMA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE CRAMP; NIFEDIPINE; POLYURIA; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; STRESS, PSYCHOLOGICAL; TACHYCARDIA; VERAPAMIL;

EID: 0033548854     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.7.693     Document Type: Article

References (21)

1. Cassileth BR, Lusk EJ, Strouse TB, et al. Psychosocial status in chronic illness: a comparative analysis of six diagnostic groups. N Engl J Med. 1984;311: 506-511.
2. Williams GH. Quality of life and its impact on hypertensive patients. Am J Med. 1987;82:98-105.
3. Frishman WH, Garofalo JL, Rothschild A, Rothschild M, Greenberg SM, Soberman J. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild and moderate systemic hypertension receiving diuretics. Am J Med. 1987;83:15-19.
4. Jachuck SJ, Brierly H, Jachuck S, Willcox PM. Managing hypertension 2: the effect of hypotensive drugs on the quality of life. J R Coll Gen Pract. 1982;32:103-105.
5. Bulpitt CJ, Fletcher AE. Quality of life evaluation of antihypertensive drugs. Pharmacoeconomics. 1992;1:95-102.
6. Levine S, Croog SH. What constitutes quality of life? a conceptualization of the dimension of life quality in healthy populations and patients with cardiovascular disease. In: Wenger NK, Mattson ME, Furberg CD, Ellison J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, NY: LeJacq Publishing; 1984:46-58.
7. Fava GA, Magnani B. Quality of life: a review of contemporary confusion. Med Sci Res. 1988;16:1051-1054.
8. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314:1657-1664.
9. Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens. 1991;4:363-373.
10. Iqbal P, Fotherby MD, Potter JF. Validation of the Spacelabs 90207 automatic non-invasive blood pressure monitor in elderly subjects. Blood Press Monitor. 1996;1:367-374.
11. White WB, Black HR, Weber MA, et al. Comparison of controlled onset extended release verapamil at bedtime and nefedine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate blood pressure product]. Am J Cardiol. 1998;81:424-431.
12. Testa MA, Anderson RB, Nackley JF, et al. Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. N Engl J Med. 1993; 328:907-913.
13. Anderson RB, Testa MA. Symptom distress checklists as a component of quality of life measurement: comparing prompted reports by patient and physician with concurrent adverse event reports via the physician. Drug Inf J. 1994;28:89-114.
14. Veit CT, Ware JE. The structure of psychological distress and well-being in general populations. J Consult Clin Psychol. 1983;51:730-742.
15. Dupuy HJ. The psychological well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CD, Ellison J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, NY: LeJacq Publishing; 1984:1-22.
16. Lee D, Desu M. A computer program for comparing k samples with right-censored data. Comput Programs Biomed. 1972;2:315-321.
17. Pillai KCS. Upper percentage points of the largest root of a matrix in multivariate analyses. Biometrika. 1967;54:189-193.
18. Norusis M. SPSS Advanced Statistics User's Guide. Chicago, III. SPSS Inc; 1990. 94-95.
19. Palmer A, Fletcher A, Hamilton G, Muriss S, Bulpitt C. A comparison of verapamil and nifedipine on quality of life. Br J Clin Pharmacol. 1990;30:365-370.
20. Schoenberger JA, Croog SH, Sudilovsky A, Levine S, Baume RM, for the Quality of Life Research Group. Self-reported side effects from antihypertensive drugs: a clinical trial. Am J Hypertens. 1990;3:123-132.
21. Weir MR, Orisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life: influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens. 1996;9:854-859.